{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:39:57Z","timestamp":1791070797477,"version":"4.1.0"},"reference-count":71,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T00:00:00Z","timestamp":1741478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82404534"],"award-info":[{"award-number":["82404534"]}]},{"name":"National Natural Science Foundation of China","award":["82173758"],"award-info":[{"award-number":["82173758"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Background: Activated hepatic stellate cells (aHSCs) play a significant role during the onset of hepatic fibrosis, ultimately leading to excessive deposition of extracellular matrix (ECM) and other typical pathological features, and thus have become a popular target for the treatment of hepatic fibrosis. However, current aHSC-centric therapy strategies achieve unsatisfactory results, mainly due to the lack of approved anti-fibrosis drugs and sufficiently efficient aHSC-targeted delivery systems. In this study, our aim was to develop an Imatinib-loaded nanoparticle delivery system based on a chondroitin sulfate derivative to enhance aHSC targeting efficiency, improve the therapeutic effect for hepatic fibrosis, and investigate the underlying mechanism. Methods: The carboxyl group of chondroitin sulfate and the amino group of 1-hexadecylamine were linked by an amide bond in this study to produce the amphiphilic carrier CS-HDA. Then, the Imatinib-loaded nanoparticles (IM-CS NPs) were designed to efficiently target aHSCs through CD44-mediated endocytosis and effectively inhibit HSC overactivation via PDGF and TGF-\u03b2 signaling pathways. Results: Both in vitro cellular uptake experiments and in vivo distribution experiments demonstrated that CS-HDA-modified nanoparticles (IM-CS NPs) exhibited a better targeting ability for aHSCs, which were subsequently utilized to treat carbon tetrachloride-induced hepatic fibrosis mouse models. Finally, significant fibrosis resolution was observed in the carbon tetrachloride-induced hepatic fibrosis mouse models after tail vein injection of the IM-CS NPs, along with their outstanding biocompatibility and biological safety. Conclusions: IM-loaded NPs based on an amphiphilic CS derivative have remarkable antifibrotic effects, providing a promising avenue for the clinical treatment of advanced hepatic fibrosis.<\/jats:p>","DOI":"10.3390\/pharmaceutics17030351","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T08:46:41Z","timestamp":1741596401000},"page":"351","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Chondroitin Sulfate-Based Imatinib Nanoparticles Targeting Activated Hepatic Stellate Cells Against Hepatic Fibrosis"],"prefix":"10.3390","volume":"17","author":[{"given":"Xunzhi","family":"Liu","sequence":"first","affiliation":[{"name":"Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5205-5209","authenticated-orcid":false,"given":"Changlong","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Chongqing University Fuling Hospital, Chongqing University, Chongqing 408099, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongling","family":"Yu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Huang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxing","family":"Feng","sequence":"additional","affiliation":[{"name":"Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqin","family":"Luo","sequence":"additional","affiliation":[{"name":"Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengying","family":"Wu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulu","family":"Tan","sequence":"additional","affiliation":[{"name":"Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxia","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, West China Hospital, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Gong","sequence":"additional","affiliation":[{"name":"Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7350-1939","authenticated-orcid":false,"given":"Peihong","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Provincial People\u2019s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1089\/jir.2020.0059","article-title":"Key Players of Hepatic Fibrosis","volume":"40","author":"Dawood","year":"2020","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Krag","year":"2021","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5152\/tjg.2018.17330","article-title":"Liver fibrosis","volume":"29","year":"2018","journal-title":"Turk. J. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1021\/acsnano.8b06924","article-title":"Golgi Apparatus-Targeted Chondroitin-Modified Nanomicelles Suppress Hepatic Stellate Cell Activation for the Management of Liver Fibrosis","volume":"13","author":"Luo","year":"2019","journal-title":"ACS Nano"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Fan, Q.Q., Zhang, C.L., Qiao, J.B., Cui, P.F., Xing, L., Oh, Y.K., and Jiang, H.L. (2020). Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy. Biomaterials, 230.","DOI":"10.1016\/j.biomaterials.2019.119616"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Azzam, M., El Safy, S., Abdelgelil, S.A., Weiskirchen, R., Asimakopoulou, A., de Lorenzi, F., Lammers, T., Mansour, S., and Tammam, S. (2020). Targeting Activated Hepatic Stellate Cells Using Collagen-Binding Chitosan Nanoparticles for siRNA Delivery to Fibrotic Livers. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12060590"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/jpet.118.256156","article-title":"Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis","volume":"370","author":"Chen","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"15827","DOI":"10.1021\/acs.nanolett.4c04820","article-title":"Hepatic Stellate Cell Membrane-Camouflaged Nanoparticles for Targeted Delivery of an Antifibrotic Agent to Hepatic Stellate Cells with Enhanced Antifibrosis Efficacy","volume":"24","author":"Cheng","year":"2024","journal-title":"Nano Lett."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Qu, K., Huang, Z., Lin, T., Liu, S., Chang, H., Yan, Z., Zhang, H., and Liu, C. (2015). New Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical Trials. Front. Pharmacol., 6.","DOI":"10.3389\/fphar.2015.00300"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"173666","DOI":"10.1016\/j.ejphar.2020.173666","article-title":"Imatinib improves insulin resistance and inhibits injury-induced neointimal hyperplasia in high fat diet-fed mice","volume":"890","author":"Pichavaram","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1517\/14740338.4.2.183","article-title":"The development and application of imatinib","volume":"4","author":"Jones","year":"2005","journal-title":"Expert. Opin. Drug Saf."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.04-2733fje","article-title":"Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo","volume":"19","author":"Wang","year":"2005","journal-title":"FASEB J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jconrel.2017.09.035","article-title":"Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis","volume":"266","author":"Shalaby","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_15","first-page":"304","article-title":"Liver Fibrosis: Causes and Methods of Assessment, A Review","volume":"53","author":"Toosi","year":"2015","journal-title":"Rom. J. Intern. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1529-8019.2011.01431.x","article-title":"Adverse cutaneous reactions secondary to tyrosine kinase inhibitors including imatinib mesylate, nilotinib, and dasatinib","volume":"24","author":"Stemmer","year":"2011","journal-title":"Dermatol. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1016\/j.bbagen.2013.06.006","article-title":"Biosynthesis and function of chondroitin sulfate","volume":"1830","author":"Mikami","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.maturitas.2014.04.015","article-title":"What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis?","volume":"78","author":"Henrotin","year":"2014","journal-title":"Maturitas"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1039\/D1OB00882J","article-title":"Synthesis, structure and midkine binding of chondroitin sulfate oligosaccharide analogues","volume":"19","author":"Maza","year":"2021","journal-title":"Org. Biomol. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"115650","DOI":"10.1016\/j.carbpol.2019.115650","article-title":"Recent advance in delivery system and tissue engineering applications of chondroitin sulfate","volume":"230","author":"Yang","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/02713683.2020.1849733","article-title":"Efficacy and Safety of Sodium Hyaluronate\/chondroitin Sulfate Preservative-free Ophthalmic Solution in the Treatment of Dry Eye: A Clinical Trial","volume":"46","year":"2021","journal-title":"Curr. Eye Res."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Chu, Y.H., Liao, W.C., Ho, Y.J., Huang, C.H., Tseng, T.J., and Liu, C.H. (2021). Targeting Chondroitin Sulfate Reduces Invasiveness of Glioma Cells by Suppressing CD44 and Integrin \u03b21 Expression. Cells, 10.","DOI":"10.3390\/cells10123594"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"115568","DOI":"10.1016\/j.carbpol.2019.115568","article-title":"Blood component ridable and CD44 receptor targetable nanoparticles based on a maleimide-functionalized chondroitin sulfate derivative","volume":"230","author":"Lee","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.apsb.2019.07.003","article-title":"Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats Cellulose acetate microspheres prepared by o\/w emulsification and solvent evaporation method","volume":"10","author":"Li","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1535370219898141","article-title":"Mechanisms of liver fibrosis and its role in liver cancer","volume":"245","author":"Dhar","year":"2020","journal-title":"Exp. Biol. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1166\/jnn.2016.11918","article-title":"Poly(lactic-co-glycolic) Acid\/Solutol HS15-Based Nanoparticles for Docetaxel Delivery","volume":"16","author":"Cho","year":"2016","journal-title":"J. Nanosci. Nanotechnol."},{"key":"ref_27","first-page":"672","article-title":"Synchronous microencapsulation of multiple components in silymarin into PLGA nanoparticles by an emulsification\/solvent evaporation method","volume":"21","author":"Xie","year":"2016","journal-title":"Pharm. Dev. Technol. Sep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-020-00411-3","article-title":"Role of liver sinusoidal endothelial cells in liver diseases","volume":"18","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/1061186X.2020.1833018","article-title":"Biomedical application of chondroitin sulfate with nanoparticles in drug delivery systems: Systematic review","volume":"29","author":"Amhare","year":"2021","journal-title":"J. Drug Target."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"107151","DOI":"10.1016\/j.intimp.2020.107151","article-title":"Amygdalin inhibits TGF\u03b21-induced activation of hepatic stellate cells (HSCs) in vitro and CCl(4)-induced hepatic fibrosis in rats in vivo","volume":"90","author":"Wang","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"152780","DOI":"10.1016\/j.phymed.2018.12.003","article-title":"Liquiritigenin inhibits hepatic fibrogenesis and TGF-\u03b21\/Smad with Hippo\/YAP signal","volume":"62","author":"Lee","year":"2019","journal-title":"Phytomedicine"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"115837","DOI":"10.1016\/j.carbpol.2020.115837","article-title":"Chondroitin sulfate derived theranostic and therapeutic nanocarriers for tumor-targeted drug delivery","volume":"233","author":"Khan","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1517\/17425240903236101","article-title":"Subcellular targeting: A new frontier for drug-loaded pharmaceutical nanocarriers and the concept of the magic bullet","volume":"6","author":"Weissig","year":"2009","journal-title":"Expert. Opin. Drug Deliv."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcis.2020.11.076","article-title":"It\u2019s what\u2019s on the inside that counts: Techniques for investigating the uptake and recycling of nanoparticles and proteins in cells","volume":"587","author":"FitzGerald","year":"2021","journal-title":"J. Colloid. Interface Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e410","DOI":"10.1002\/ctm2.410","article-title":"Rebalancing TGF-\u03b2\/Smad7 signaling via Compound kushen injection in hepatic stellate cells protects against liver fibrosis and hepatocarcinogenesis","volume":"11","author":"Yang","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"ref_36","first-page":"511","article-title":"Liver cell models in in vitro toxicology","volume":"106","author":"Guillouzo","year":"1998","journal-title":"Environ. Health Perspect."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/BF02796367","article-title":"Conditions affecting primary cell cultures of functional adult rat hepatocytes. II. Dexamethasone enhanced longevity and maintenance of morphology","volume":"12","author":"Laishes","year":"1976","journal-title":"In Vitro"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1073\/pnas.82.10.3252","article-title":"Maintenance of differentiated rat hepatocytes in primary culture","volume":"82","author":"Isom","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/jhbp.245","article-title":"Recent advancement of molecular mechanisms of liver fibrosis","volume":"22","author":"Seki","year":"2015","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bbadis.2017.06.027","article-title":"Animal models of biliary injury and altered bile acid metabolism","volume":"1864 Pt B","author":"Mariotti","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.lfs.2019.04.042","article-title":"What is the role of peptide fragments of collagen I and IV in health and disease?","volume":"228","author":"Kisling","year":"2019","journal-title":"Life Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6850","DOI":"10.1111\/febs.15776","article-title":"A guide to the composition and functions of the extracellular matrix","volume":"288","author":"Karamanos","year":"2021","journal-title":"FEBS J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2015.11.001","article-title":"Extracellular matrix structure","volume":"97","author":"Theocharis","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix in development and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1111\/febs.14818","article-title":"The extracellular matrix as a multitasking player in disease","volume":"286","author":"Theocharis","year":"2019","journal-title":"FEBS J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/apt.15773","article-title":"Review article: The signalling and functional role of the extracellular matrix in the development of liver fibrosis","volume":"52","author":"Villesen","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Caligiuri, A., Gentilini, A., Pastore, M., Gitto, S., and Marra, F. (2021). Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression. Cells, 10.","DOI":"10.3390\/cells10102759"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3904\/kjim.2018.214","article-title":"Immunological measurement of aspartate\/alanine aminotransferase in predicting liver fibrosis and inflammation","volume":"35","author":"Kim","year":"2020","journal-title":"Korean J. Intern. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/hep.31418","article-title":"Sirt6 Alleviated Liver Fibrosis by Deacetylating Conserved Lysine 54 on Smad2 in Hepatic Stellate Cells","volume":"73","author":"Zhang","year":"2021","journal-title":"Hepatology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/aps.2010.192","article-title":"Mixed micelles loaded with silybin-polyene phosphatidylcholine complex improve drug solubility","volume":"32","author":"Duan","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jconrel.2018.10.009","article-title":"Application of polydopamine in tumor targeted drug delivery system and its drug release behavior","volume":"290","author":"Wang","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2533\/chimia.2012.308","article-title":"Pharmaceutical technology at the service of targeted drug delivery","volume":"66","author":"Delie","year":"2012","journal-title":"Chimia"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1248\/bpb.b20-00815","article-title":"Mechanotransduction-Targeting Drugs Attenuate Stiffness-Induced Hepatic Stellate Cell Activation in Vitro","volume":"44","author":"Sakai","year":"2021","journal-title":"Biol. Pharm. Bull."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Friedman","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MAT.0b013e318239fce5","article-title":"A novel technique for hepatic progenitor cell isolation from normal adult rat livers","volume":"58","author":"Guo","year":"2012","journal-title":"ASAIO J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jhep.2010.04.037","article-title":"Characterization of two F4\/80-positive Kupffer cell subsets by their function and phenotype in mice","volume":"53","author":"Kinoshita","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Endo-Umeda, K., Nakashima, H., Komine-Aizawa, S., Umeda, N., Seki, S., and Makishima, M. (2018). Liver X receptors regulate hepatic F4\/80+CD11b+ Kupffer cells\/macrophages and innate immune responses in mice. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-27615-7"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.4161\/cc.7.18.6700","article-title":"Efficient differentiation of hESCs into endothelial cells in vitro is secured by epigenetic changes","volume":"7","author":"Lagarkova","year":"2008","journal-title":"Cell Cycle"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Rahman, M.A. (2019). Collagen of Extracellular Matrix from Marine Invertebrates and Its Medical Applications. Mar. Drugs, 17.","DOI":"10.3390\/md17020118"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1158\/0008-5472.CAN-17-3844","article-title":"CTGF Mediates Tumor-Stroma Interactions between Hepatoma Cells and Hepatic Stellate Cells to Accelerate HCC Progression","volume":"78","author":"Makino","year":"2018","journal-title":"Cancer Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2169\/internalmedicine.47.0595","article-title":"Retrospective evaluation of serum markers APRI and AST\/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma","volume":"47","author":"Lin","year":"2008","journal-title":"Intern. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"7299","DOI":"10.3748\/wjg.v26.i46.7299","article-title":"Untargeted metabolomics characteristics of nonobese nonalcoholic fatty liver disease induced by high-temperature-processed feed in Sprague-Dawley rats","volume":"26","author":"Xue","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1007\/s10753-017-0646-x","article-title":"Aucubin Alleviates Bleomycin-Induced Pulmonary Fibrosis in a Mouse Model","volume":"40","author":"Zhou","year":"2017","journal-title":"Inflammation"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"6175091","DOI":"10.1155\/2019\/6175091","article-title":"Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-\u03b21\/Smad3 and TGF-\u03b21\/p38 MAPK Pathways","volume":"2019","author":"Liu","year":"2019","journal-title":"Mediators Inflamm."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","article-title":"Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets","volume":"22","author":"Zhang","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Wang, W., Yan, J., Wang, H., Shi, M., Zhang, M., Yang, W., Peng, C., and Li, H. (2014). Rapamycin ameliorates inflammation and fibrosis in the early phase of cirrhotic portal hypertension in rats through inhibition of mTORC1 but not mTORC2. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0083908"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"113496","DOI":"10.1016\/j.jep.2020.113496","article-title":"Kadsura heteroclita stem ethanol extract protects against carbon tetrachloride-induced liver injury in mice via suppression of oxidative stress, inflammation, and apoptosis","volume":"267","author":"Yu","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","article-title":"Pathogenesis of liver cirrhosis","volume":"20","author":"Zhou","year":"2014","journal-title":"World J. Gastroenterol."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/3\/351\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:49:42Z","timestamp":1760028582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/3\/351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,9]]},"references-count":71,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["pharmaceutics17030351"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics17030351","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,9]]}}}